RankAlpha logo
Back to Rankings

ASTH

Astrana HealthA
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-22
View Chart
Current thesis
The post-earnings bull read is straightforward: Q1 showed 56% revenue growth, 82% adjusted EBITDA growth, strong free cash flow, reiterated guidance, and early evidence that full-risk contract conversions and Prospect integration are tracking acceptably [#8-K-2026-05-07].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +1.2.
What can break
A large portion of the quarter's revenue growth came from the Prospect acquisition, so any integration miss or weaker-than-expected contribution could pressure the earnings-power narrative [#10-Q-2026-05-08].
Momentum
90
Value
59
Sentiment
46
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $36.00 · Bull $46.00 · Bear $28.00
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $49.33
Why
Momentum90 · Δ7d +1.2
Value59 · Δ7d +0.7
Sentiment46 · Δ7d +5.5
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
90
26% active weight
Current posture
7d trendFlat
Δ7d
+1.2
Δ21d
+3.6
Value
59
39% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
+1.1
Sentiment
46
34% active weight
Current posture
7d trendImproving
Δ7d
+5.5
Δ21d
-0.3
Why this grade

Composite grade A. Momentum 90.1 / Value 58.8 / Sentiment 46.3

Fundamentals (TTM)
As of 2026-07-22
Market Cap
$2.08B
Beta
0.91
Shares Out
49.58M
P/E (TTM)
144.5
P/S (TTM)
0.47
P/FCF (TTM)
15.49
Rev YoY
+55.6%
EPS YoY
+114.8%
Gross Margin
+9.1%
Op Margin
+2.1%
Net Debt
$648.54M
Current Ratio
1.35
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology